The New England Journal of Medicine | Back to the Future: The Therapeutic Potential of Psychedelic Drugs

Original Pub: New England Journal of Medicine
Publish Date: April 14, 2021
Author: Jeffrey A. Lieberman, M.D.

In 'The Doors of Perception', Aldous Huxley described his trial of mescaline as "the most extraordinary and significant experience available to human beings this side of the 'Beatific Vision'." His exegesis was preceded by the synthesis of the hallucinogen lysergic acid diethylamide (LSD) by Sandoz chemist Albert Hoffman in 1938 and was followed by Hoffman's extraction of psilocybin from Psilocybe mexicana in 1959.

Read this published article (NEJM.org)